Clinical Trial Update: A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis [Phase 2]

View source ↗

Summary

Phase 2 trial of CD5789 cream in adults and adolescents with lamellar ichthyosis was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lamellar Ichthyosis

Drugs mentioned

• CD5789 cream

Snippet

Sponsor: Mayne Pharma International Pty Ltd | Conditions: Lamellar Ichthyosis | Phase 2 | Status: TERMINATED | Results posted: 2023-08-14